NCT05063591 · OUTCOME

Proportion of Eligible Patients Choosing to Participate in the Care Model Under Study Rather Than Standard of Care.

Removing Transfusion Dependence as a Barrier to Hospice Enrollment · Source last updated 2026-01-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: COUNT_OF_PARTICIPANTS
Unit: Participants
Interval / dispersion: Not reported
Time frame: Through study completion, on average 2 years

What was measured

Measured as: the number of eligible patients approached and number who elect to enter the study and participate in the novel care model rather than through the traditional hospice care model.

Analysis population: Eligible patients approached for participation

Groups in this outcome

Intervention Arm

Patients with aggressive hematologic malignancies who are hospice eligible, not pursuing further cancer directed therapy, and whose primary hematologist is planning to initiate a conversation regarding transition to hospice will be eligible for enrollment. Transfusion support: Patients will be offered symptom-driven transfusion support in addition to standard hospice care

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Intervention Arm	22

Reported measurements

Source class 1

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Intervention Arm	10	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
10

denoms

counts
group Id
OG000
value
22
units
Participants

description

Measured as: the number of eligible patients approached and number who elect to enter the study and participate in the novel care model rather than through the traditional hospice care model.

groups

description
Patients with aggressive hematologic malignancies who are hospice eligible, not pursuing further cancer directed therapy, and whose primary hematologist is planning to initiate a conversation regarding transition to hospice will be eligible for enrollment. Transfusion support: Patients will be offered symptom-driven transfusion support in addition to standard hospice care
id
OG000
title
Intervention Arm

param Type

COUNT_OF_PARTICIPANTS

population Description

Eligible patients approached for participation

reporting Status

POSTED

time Frame

Through study completion, on average 2 years

title

Proportion of Eligible Patients Choosing to Participate in the Care Model Under Study Rather Than Standard of Care.

type

PRIMARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice